EHRA Premium Access

Statin use improves the outcomes in patients with atrial fibrillation: A population-based study

Congress Presentation

About the speaker

Miss Jiayi Huang

The University of Hong Kong, Hong Kong (Hong Kong)
0 follower

7 more presentations in this session

5 years incident stroke, heart failure, acute myocardial infarction, and death in patients having undergone atrial fibrillation ablation according to BMI

Speaker: Doctor J. Toennesen (Gentofte, DK)


Morphology-Voltage-P-wave-duration (MVP) score to select patients for continuous atrial fibrillation screening to prevent stroke

Speaker: Doctor L. Xing (Copenhagen, DK)


The effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a Belgian nationwide cohort study

Speaker: Mr M. Grymonprez (Ghent, BE)


How good is time-in-therapeutic-range defined warfarin treatment compared to standard dose direct oral anticoagulants? Incidence of stroke in atrial fibrillation in a nationwide registry study.

Speaker: Doctor M. Lehto (Helsinki, FI)


Racial differences in atrial fibrillation-related bleeding and mortality.

Speaker: Doctor K. Dongseon (Seoul, KR)


Access the full session

Atrial Fibrillation - Round 1 - Stroke - OAC

Speakers: Miss J. Huang, Doctor J. Toennesen, Doctor L. Xing, Mr M. Grymonprez, Doctor M. Lehto...

About the event


EHRA 2023

16 April - 18 April 2023

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb